European Union: Pharmaceutical Sector Investigations Signal Increased Focus on Broadened Theories of Harm

Cleary Gottlieb partner Patrick Bock and associate Basak Arslan authored the article, “European Union: Pharmaceutical Sector Investigations Signal Increased Focus on Broadened Theories of Harm,” which was published by Global Competition Review.

The article provides an overview of the European competition regulators’ enforcement activities in the pharmaceutical industry from 2018 to 2022. It identifies the key trends and themes underlying the European Commission’s and the national competition authorities’ article 101 and 102 of the Treaty on the Functioning of the European Union investigations and the European Commission’s merger review decisions since 2018.

Read the article here.